Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
ASHIMASYN.NS Stock Summary
Top 10 Correlated ETFs
ASHIMASYN.NS
In the News
ASHIMASYN.NS Financial details
Company Rating
Neutral
Market Cap
3.65B
Income
-53M
Revenue
2.21B
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
226
Optionable
No
Shortable
Yes
Earnings
08 Feb 2024
P/E
-34.42
Forward P/E
-
PEG
2.64
P/S
2.01
P/B
1.75
P/C
-
P/FCF
-
Quick Ratio
0.51
Current Ratio
2.08
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-0.28
EPS next Y
-
EPS next Q
-
EPS this Y
-137.63%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
-6.01%
Revenue Q/Q
55.76%
EPS Q/Q
-357.14%
-
-
-
-
SMA20
-15.54%
SMA50
-8.29%
SMA100
23.77%
Inst Own
-
Inst Trans
-
ROA
-3%
ROE
-10%
ROC
-0.02%
Gross Margin
74%
Oper. Margin
-4%
Profit Margin
-6%
Payout
-
Shs Outstand
191.66M
Shs Float
42.14M
-
-
-
-
Target Price
-
52W Range
12.15-26.15
52W High
-29.23%
52W Low
+53.33%
RSI
42.32
Rel Volume
0.07
Avg Volume
1.39M
Volume
101.97K
Perf Week
-4.66%
Perf Month
-16.17%
Perf Quarter
17.57%
Perf Half Y
33.82%
-
-
-
-
Beta
0.876
-
-
Volatility
0.29%, 1.65%
Prev Close
1.1%
Price
18.4
Change
-3.66%
ASHIMASYN.NS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-03-31
Metric | History | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 14.73 | 14.72 | 7.31 | 10.75 | 10.89 | |
Net income per share | 0.93 | -0.18 | -0.6 | 0.93 | -0.35 | |
Operating cash flow per share | -1.4 | 0.2 | -0.42 | -1.38 | -1.26 | |
Free cash flow per share | -1.45 | -0.22 | -0.46 | -1.92 | -2.22 | |
Cash per share | 1.17 | 1.57 | 2.76 | 1.41 | 1.66 | |
Book value per share | 9.29 | 11.53 | 10.91 | 11.8 | 11.59 | |
Tangible book value per share | 9.28 | 11.51 | 10.9 | 11.8 | 11.59 | |
Share holders equity per share | 9.29 | 11.53 | 10.91 | 11.8 | 11.59 | |
Interest debt per share | 1.45 | 1.73 | 1.59 | 0.94 | 1.84 | |
Market cap | 2.41B | 613.31M | 3.02B | 2.71B | 2.37B | |
Enterprise value | 2.55B | 807.41M | 3.2B | 2.73B | 2.49B | |
P/E ratio | 13.55 | -18.15 | -26.32 | 15.13 | -35.57 | |
Price to sales ratio | 0.86 | 0.22 | 2.15 | 1.32 | 1.14 | |
POCF ratio | -9.01 | 15.69 | -37.55 | -10.27 | -9.89 | |
PFCF ratio | -8.67 | -14.71 | -34.03 | -7.37 | -5.61 | |
P/B Ratio | 1.36 | 0.28 | 1.44 | 1.2 | 1.07 | |
PTB ratio | 1.36 | 0.28 | 1.44 | 1.2 | 1.07 | |
EV to sales | 0.9 | 0.29 | 2.28 | 1.32 | 1.2 | |
Enterprise value over EBITDA | -39.66 | 79.16 | -67.43 | -47.46 | -197.83 | |
EV to operating cash flow | -9.5 | 20.65 | -39.84 | -10.34 | -10.42 | |
EV to free cash flow | -9.14 | -19.36 | -36.11 | -7.42 | -5.92 | |
Earnings yield | 0.07 | -0.06 | -0.04 | 0.07 | -0.03 | |
Free cash flow yield | -0.12 | -0.07 | -0.03 | -0.14 | -0.18 | |
Debt to equity | 0.14 | 0.14 | 0.13 | 0.07 | 0.15 | |
Debt to assets | 0.1 | 0.1 | 0.1 | 0.05 | 0.1 | |
Net debt to EBITDA | -2.04 | 19.03 | -3.88 | -0.29 | -10.09 | |
Current ratio | 3.43 | 2.75 | 3.04 | 2.29 | 2.38 | |
Interest coverage | -2.13 | -3.44 | -1.68 | -5.43 | -4.01 | |
Income quality | 1.85 | -1.16 | 0.71 | 1.79 | 3.62 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0.15 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0.04 | -2.07 | 0.1 | 0.39 | 0.76 | |
Capex to revenue | 0 | -0.03 | -0.01 | -0.05 | -0.09 | |
Capex to depreciation | -0.28 | -1.5 | -0.18 | -3.34 | -4.41 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 13.94 | 6.76 | 12.12 | 15.76 | 9.56 | |
ROIC | -0.01 | -0.09 | -0.02 | -0.03 | -0.05 | |
Return on tangible assets | 0.07 | -0.01 | -0.04 | 0.06 | -0.02 | |
Graham Net | 1.69 | -0.2 | 1.14 | -0.48 | -0.92 | |
Working capital | 972M | 923.7M | 833.2M | 982.9M | 928.9M | |
Tangible asset value | 1.78B | 2.21B | 2.09B | 2.26B | 2.2B | |
Net current asset value | 754M | 698.5M | 641.9M | 833M | 601.2M | |
Invested capital | 0.14 | 0.14 | 0.13 | 0.07 | 0.15 | |
Average receivables | 695.45M | 400.8M | 153.25M | 181.6M | 183.4M | |
Average payables | 383.4M | 349.8M | 297M | 316.15M | 359.05M | |
Average inventory | 526.4M | 532.5M | 476M | 568.15M | 783.5M | |
Days sales outstanding | 82.36 | 21.33 | 36.9 | 39.23 | 25.62 | |
Days payables outstanding | 66.93 | 79.74 | 87.54 | 111.93 | 96 | |
Days of inventory on hand | 102.46 | 120.83 | 154.43 | 202.96 | 260.45 | |
Receivables turnover | 4.43 | 17.11 | 9.89 | 9.3 | 14.25 | |
Payables turnover | 5.45 | 4.58 | 4.17 | 3.26 | 3.8 | |
Inventory turnover | 3.56 | 3.02 | 2.36 | 1.8 | 1.4 | |
ROE | 0.1 | -0.02 | -0.05 | 0.08 | -0.03 | |
Capex per share | -0.05 | -0.42 | -0.04 | -0.54 | -0.96 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q3
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 3.03 | 1.99 | 2.78 | 2.8 | 4.14 | |
Net income per share | -0.12 | -0.31 | -0.08 | -0.07 | 0.18 | |
Operating cash flow per share | 0.11 | 0.11 | 0.11 | 0.12 | 0.13 | |
Free cash flow per share | 0.11 | 0.11 | 0.11 | 0.12 | 0.13 | |
Cash per share | 1.72 | 1.65 | 1.42 | 2.18 | 0 | |
Book value per share | 11.94 | 11.49 | 11.49 | 11.98 | 0 | |
Tangible book value per share | 0 | 11.49 | 0 | 11.98 | 0 | |
Share holders equity per share | 11.94 | 11.49 | 11.49 | 11.98 | 0 | |
Interest debt per share | 0.03 | 1.73 | 0.02 | 4.47 | 0.09 | |
Market cap | 3.27B | 2.39B | 2.73B | 2.92B | 3.33B | |
Enterprise value | 3.6B | 2.51B | 3B | 3.39B | 3.33B | |
P/E ratio | -35.06 | -10.11 | -43.49 | -57.5 | 24.17 | |
Price to sales ratio | 5.62 | 6.25 | 5.12 | 5.75 | 4.21 | |
POCF ratio | 157.11 | 115.83 | 127.62 | 133.99 | 138.56 | |
PFCF ratio | 157.11 | 115.83 | 127.62 | 133.99 | 138.56 | |
P/B Ratio | 1.43 | 1.08 | 1.24 | 1.34 | 0 | |
PTB ratio | 1.43 | 1.08 | 1.24 | 1.34 | 0 | |
EV to sales | 6.18 | 6.59 | 5.63 | 6.67 | 4.21 | |
Enterprise value over EBITDA | 183.53 | -57.12 | -6.01K | 583.84 | 55.51 | |
EV to operating cash flow | 172.94 | 122 | 140.33 | 155.33 | 138.56 | |
EV to free cash flow | 172.94 | 122 | 140.33 | 155.33 | 138.56 | |
Earnings yield | -0.01 | -0.02 | -0.01 | 0 | 0.01 | |
Free cash flow yield | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Debt to equity | 0 | 0.15 | 0 | 0.37 | 0 | |
Debt to assets | 0 | 0.1 | 0 | 0.2 | 0 | |
Net debt to EBITDA | 16.8 | -2.89 | -544 | 80.22 | 0 | |
Current ratio | 0 | 2.38 | 0 | 2.08 | 0 | |
Interest coverage | 1.51 | -12.94 | -3.23 | -0.64 | 2.8 | |
Income quality | -0.89 | -0.35 | -1.36 | -1.72 | 0.69 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0.23 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0.93 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 5.71 | 8.92 | 4.6 | 4.34 | 0 | |
ROIC | 0 | -0.03 | -0.01 | 0 | 0 | |
Return on tangible assets | 0 | -0.02 | 0 | 0 | 0 | |
Graham Net | 1.72 | -0.91 | 1.42 | -3.03 | 0 | |
Working capital | 329.3M | 928.9M | 272M | 1.23B | 0 | |
Tangible asset value | 0 | 2.2B | 0 | 2.17B | 0 | |
Net current asset value | 329.3M | 601.2M | 272M | 474.3M | 0 | |
Invested capital | 0 | 0.15 | 0 | 0.37 | 0 | |
Average receivables | 110.3M | 72.65M | 72.65M | 90.7M | 90.7M | |
Average payables | 161.15M | 147.2M | 147.2M | 236.95M | 236.95M | |
Average inventory | 366.7M | 399.35M | 399.35M | 810.4M | 810.4M | |
Days sales outstanding | 0 | 34.27 | 0 | 32.16 | 0 | |
Days payables outstanding | 0 | 176.4 | 0 | 165.7 | 0 | |
Days of inventory on hand | 0 | 478.58 | 0 | 566.71 | 0 | |
Receivables turnover | 0 | 2.63 | 0 | 2.8 | 0 | |
Payables turnover | 0 | 0.51 | 0 | 0.54 | 0 | |
Inventory turnover | 0 | 0.19 | 0 | 0.16 | 0 | |
ROE | -0.01 | -0.03 | -0.01 | -0.01 | 0 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
ASHIMASYN.NS Frequently Asked Questions
What is Ashima Limited stock symbol ?
Ashima Limited is a IN stock and trading under the symbol ASHIMASYN.NS
What is Ashima Limited stock quote today ?
Ashima Limited stock price is $18.4 today.
Is Ashima Limited stock public?
Yes, Ashima Limited is a publicly traded company.